Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer

Richard A Anderson; Mikkel Rosendahl; Thomas W Kelsey; David A Cameron

doi:10.1016/j.ejca.2013.07.014

Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer

Richard A Anderson, Mikkel Rosendahl, Thomas W Kelsey, David A Cameron

134 Citations (Scopus)

Abstract

Improving survival for women with early breast cancer (eBC) requires greater attention to the consequences of treatment, including risk to ovarian function. We have assessed whether biochemical markers of the ovarian reserve might improve prediction of chemotherapy related amenorrhoea.

Original language	English
Journal	European journal of cancer (Oxford, England : 1990)
Volume	49
Issue number	16
Pages (from-to)	3404-11
Number of pages	8
ISSN	0959-8049
DOIs	https://doi.org/10.1016/j.ejca.2013.07.014
Publication status	Published - Nov 2013

Access to Document

10.1016/j.ejca.2013.07.014

Cite this

@article{0cf24f196936435d87fa5add8687509b,

title = "Pretreatment anti-M{\"u}llerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer",

abstract = "Improving survival for women with early breast cancer (eBC) requires greater attention to the consequences of treatment, including risk to ovarian function. We have assessed whether biochemical markers of the ovarian reserve might improve prediction of chemotherapy related amenorrhoea.",

author = "Anderson, \{Richard A\} and Mikkel Rosendahl and Kelsey, \{Thomas W\} and Cameron, \{David A\}",

year = "2013",

month = nov,

doi = "10.1016/j.ejca.2013.07.014",

language = "English",

volume = "49",

pages = "3404--11",

journal = "European journal of cancer (Oxford, England : 1990)",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "16",

}

TY - JOUR

T1 - Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer

AU - Anderson, Richard A

AU - Rosendahl, Mikkel

AU - Kelsey, Thomas W

AU - Cameron, David A

PY - 2013/11

Y1 - 2013/11

N2 - Improving survival for women with early breast cancer (eBC) requires greater attention to the consequences of treatment, including risk to ovarian function. We have assessed whether biochemical markers of the ovarian reserve might improve prediction of chemotherapy related amenorrhoea.

AB - Improving survival for women with early breast cancer (eBC) requires greater attention to the consequences of treatment, including risk to ovarian function. We have assessed whether biochemical markers of the ovarian reserve might improve prediction of chemotherapy related amenorrhoea.

UR - https://www.scopus.com/pages/publications/84885182696

U2 - 10.1016/j.ejca.2013.07.014

DO - 10.1016/j.ejca.2013.07.014

M3 - Journal article

C2 - 23968732

SN - 0959-8049

VL - 49

SP - 3404

EP - 3411

JO - European journal of cancer (Oxford, England : 1990)

JF - European journal of cancer (Oxford, England : 1990)

IS - 16

ER -

Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer

Abstract

Access to Document

Other files and links

Fingerprint

Cite this